BIOL
Biolase, Inc.
BIOL
BIOL
Delisted
BIOL was delisted on the 18th of June, 2024.
31 hedge funds and large institutions have $12.4M invested in Biolase, Inc. in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.02M | |
| 2 | +$369K | |
| 3 | +$154K | |
| 4 |
Two Sigma Investments
New York
|
+$76K |
| 5 |
Goldman Sachs
New York
|
+$48.7K |
Top Sellers
| 1 | -$516K | |
| 2 | -$400K | |
| 3 | -$257K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$255K |
| 5 |
Millennium Management
New York
|
-$123K |